Drug Trial Radar · NCT04297592
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
Last checked: Nov 19, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
4,618
Planned (sponsor's estimate)
Start
Jun 11, 2020
Primary completion
Jan 2027
Study completion Jan 2028
Sponsor
- Lead sponsor
- Mayo ClinicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 5, 2020
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine the effectiveness of a 7-day course of an oral, prophylactic antibiotic on the incidence of periprosthetic joint infection and wound complications following primary total hip and knee arthroplasty in a high-risk patient population.
Conditions
- Infections Joint Prosthetic
- Overweight or Obesity
- MSSA Colonization
- MRSA
- Chronic Kidney Diseases
- Diabetes
- Autoimmune Diseases
- Inflammatory Disease
- Tobacco Use
Interventions
CephalexinDrug
500 mg oral tablet, 4 times daily for 7 days
DoxycyclineDrug
100 mg oral tablet, 2 times daily for 7 days
CefadroxilDrug
500 mg oral tablet, 2 times daily for 7 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Periprosthetic joint infectionsTime frame: Within 90-days primary hip or knee arthroplasty
- Periprosthetic joint infectionsTime frame: Within 1-year of primary hip or knee arthroplasty
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of Iowa Hospitals & Clinics
Iowa City, Iowa
Mayo Clinic
Rochester, Minnesota
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.